Video

Emerging Treatment Options for Patients with HER2+ Metastatic Colorectal Cancer

Discussion centered around emerging treatment options for patients with HER2+ mCRC, including trastuzumab deruxtucan.

Video Player is loading.
Current Time 0:00
Duration 4:51
Loaded: 0%
Stream Type LIVE
Remaining Time 4:51
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected

Related Content